Cold Chain Storage for Vaccines and Biomedical Products
Wide Temperature Range and Model Selection for Evolving Storage Requirements for COVID-19 and Other Pharmaceuticals
Vaccine potency relies on protection against temperature extremes through proper storage at every level of the cold chain. While the focus of temperature control is often on overheating, vaccines can be just as susceptible to freezing risks. Learn how to protect your vaccines with this free ebook.
PHCbi brand refrigerators and freezers are engineered from the inside out to create, maintain and restore precise temperatures that are not commonly found with household or commercial cabinets.
PHCbi brand pharmaceutical refrigerators and biomedical freezers offer a comprehensive selection of storage solutions for high-value vaccines and other biologics. These cabinets are based on high performance refrigeration platforms engineered for reliability, temperature uniformity, fast temperature recovery and tolerance for real-world conditions.
Solutions for the Cold Chain Spectrum
New vaccines are emerging in response to the COVID-19 pandemic. Early evidence suggests novel vaccine storage temperatures may require a wider range of the cold chain spectrum. Some vaccines may require multiple temperature storage points prior to administration. Are you prepared for emerging COVID-19 vaccine storage? PHCbi brand products can help.
The Changing Landscape
Proposed vaccine storage temperatures are based on initial data from various sources in the public domain at time of publication. Actual storage temperatures will be approved by the FDA and regulated by the CDC. Government agencies and individual vaccine manufacturers will mandate required product storage temperatures.
Safe Vaccine Storage Begins with Product Selection
PHCbi pharmaceutical refrigerators and freezers satisfy any storage protocol or space requirement. Robust refrigeration systems and cabinet designs assure temperature uniformity, reliability and energy efficiency. All are engineered to maintain required temperatures for product viability and to achieve rapid temperature recovery after multiple door openings.
Ultra-Low Temperature Freezers, -60°C to -80°C
Ultra-low temperature freezers are required for storage of mRNA, viral vector and non-replicating viral vector vaccines. Other applications include short and long-term storage of clinical specimens.
Biomedical Freezers, -40°C
For vaccine development and storage of enzymes and other biomaterials according to manufacturers' inserts or directives.
Biomedical Freezers, -20°C
For intermediate term storage of emerging vaccines, feedstocks, and other biomaterials according to manufacturers' inserts or directives.
Biomedical Refrigerator/Freezer Combo, 2°C to 8°C, and -20°C
Space-saving cabinets designed for both refrigerator and freezer functions in the same footprint. Refrigerator and freezer systems are independent for maximum stored product safety.
Pharmaceutical Refrigerators, 2°C to 8°C
For short-term storage of vaccines days prior to administration.
PHC Corporation of North America
PHC Corporation of North America is a subsidiary of PHC Holdings Corporation, Tokyo, Japan, a global leader in development, design and manufacturing of laboratory equipment for biopharmaceutical, life sciences, academic, healthcare and government markets. Product lines under the new PHCbi brand include the space saving and energy efficient VIP® ECO, TwinGuard® and VIP Series ultra-low temperature freezers, cryogenic and biomedical freezers, pharmacy and high performance refrigerators, cell culture CO2 and multigas incubators and Drosophila/plant growth chambers. For more product information, please call PHC Corporation of North America at 800-858-8442, email firstname.lastname@example.org or visit www.phchd.com/us/biomedical.